ORAL COMMUNICATION 2

FDG PET Imaging in Dementia

• Antonia Bose: Quantifying the effect of varying levels of systemic blood sugar on cerebral energy metabolism
• Valentin Riedl: The energetic costs of signaling as a proxy of cognition in health and disease
• Antoine Rogeau: Unsupervised anomaly detection of brain [18F]-FDG PET in Alzheimer's disease and frontotemporal dementia
• Florent Hives: Cerebral metabolism in patients with typical vs atypical frontotemporal dementia and alzheimer’s disease
• Michal Pudis: Evaluation of Brain Metabolic Pattern in Niemann-Pick Type C Disease

75min

COFFEE BREAK

30min

SATELLITE SYMPOSIUM 3

Life Molecular Imaging

45min

ORAL COMMUNICATION 3

PET Imaging in Dementia - Other Tracers than FDG

• Liang Gong (China): Sex-specific entorhinal cortex functional connectivity in cognitively normal older adults with amyloid-β pathology
• Cecilia Boccalini (Switzerland): Early-phase [18F]Flortaucipir tau-PET as a measure of neurodegeneration: a comparison with [18F]FDG-PET and early-phase amyloid-PET
• Ricardo Espinosa (Switzerland): Brain connectivity of early-phase amyloid imaging in Alzheimer's disease
• Norman Koglin (Germany: Experiences from clinical research and routine use with neuraceq amyloid pet - a decade of post-authorisation insights.
• Eóin Molloy (Germany): Establishment of a deeply phenotyped cohort to determine factors of successful cognitive ageing
• Michal Pudis (Spain) : Evaluation of the Utility of PET/MRI with Amyloid in the Diagnosis of Cerebral Amyloid Angiopathy

90mn

LUNCH

75min

LECTURE SESSION 2

Imaging in Psychiatry
Chairs: Julia Sacher (Germany)- Koen van Laere (Belgium)

• Gerhard Gründer (Germany): Clinical Imaging in Psychiatry
• Gitte M. Knudsen (Denmark): Dynamic Coupling of Brain Neuronal and Neurotransmitter Systems
• Rupert Lanzenberger (Austria): New targets, new approaches, new biomarkers in neuroimaging: QUO VADIS?

90min

COFFEE BREAK

30min

ORAL COMMUNICATION 4

Imaging Other Brain States

• Denise Visser (The Netherlands): Imaging the post-COVID brain 2 years after infection using [18F]DPA-714 PET and MRI: is it all between the ears?
• Maja Badendick (Germany): Central α4β2*nicotinic receptor availability (nAChR) availability is significantly influenced by leptin in human obesity (OB)
• Melanie Storch (Germany): Hypothalamic volume in pedophilia with or without child sexual offense
• Sebastien Heyer (France): Brain 18F-FDG PET: an efficient tool at the initial diagnosis of non-lesional late-onset epilepsy

60min

AWARDS

15min

SATELLITE SYMPOSIUM 4

GE HealthCare

45min

NETWORKING EVENT

LECTURE SESSION 3

The ATN Concept in AD
Chairs: Donatienne Van Weehaeghe (Belgium), Igor Yakushev (Germany)

• Emrah Düzel (Germany): Super Aging – A Great Model to Improve Understanding of AD
• Nik Weißkopf (Germany): High-Field MRI – Improved Insights Into the Brain
• Markus Otto (Germany): Fluid Biomarkers for ATN Staging in AD

90min

COFFEE BREAK

30min

SPECIAL LECTURE

Imaging Parkinsonian Syndromes:

• My Jonasson: 11C-PE2I-PET for Differential Diagnosis of Parkinsonism

30 mn

ORAL COMMUNICATION 5

Imaging Parkinsonian Syndromes:

• Anthime FLAUS: CT-guided spatial normalisation of [123]I-FP-CIT SPECT images versus SPECT-guided normalisation to discriminate abnormal from normal putaminal uptake
• Franziska Albrecht: Predicting the brain age of people with Parkinson’s disease utilizing minimally processed magnetic resonance images
• Elon Wallert: Accuracy of AI-driven susceptibility map-weighted MRI analyses to differentiate neurodegenerative from non-neurodegenerative parkinsonism

60min

LUNCH

75min

RAPID FIRE SESSION

Chairs : Marianne Patt (Germany) Swen Hesse (Germany)

• Sara Cabras (Italy): Investigating the role of 2-[18F]FDG-PET as a biomarker of upper motor neuron involvement in Amyotrophic Lateral Sclerosis.
• Liang Gong (China): Personalized Brain Network Mechanisms and Prediction of Chronic Insomnia Disorder with Comorbid Depression.
• Hamza Khan (Belgium): Predicting Disability Progression in People with Multiple Sclerosis: Combining Volumetric and Radiomics Features from T2-Weighted FLAIR MR Images.
• Marie Stroske (Germany): Hypothalamus and Third Ventricle Volume of Patients with Affective Disorders.
• Peter Schoenknecht (Germany): Mammillary body and hypothalamic volumes in mood disorders.
• Zixiao Yin (Germany, China): Generalized sleep decoding with basal ganglia signals in multiple movement disorders.
• Frederik Buchholz (Germany): Subgenual ACC gray matter volumes in mood disorders.
• Laurent Sheybani (United-Kingdom): Wake slow waves impact epileptic discharges and cognition in focal human epilepsy.
• Uta Claußnitzer (Germany): Development of an Interactive Segmentation Algorithm of the Hippocampus Using 7T T1 Weighted Mr-Images in Humans.
• Kerrin Pine (Germany): Ultrahigh field quantitative MRI for repeatable characterization of the subcortex.
• Julia Wolff (Germany): A Semi-Automated Algorithm for Hypothalamus Volumetry in 3-Tesla Magnetic Resonance Images.
• Benedikt Kürzinger (Germany): Automated structural analysis of the amygdala in affective disorders using 7T MRI in vivo.
• Rajendra Badgaiyan (United States): Use of Dynamic Neurotransmitter Imaging technique to study neuropathology of psychiatric and neurological conditions.
• Dimitra Kiakou (Czech Republic): Functional MRI-based classification of Deep Brain Stimulation states in Parkinson’s disease.

140min

CONCLUSION

25min

END OF THE CONFERENCE